Pubblicazioni Scientifiche

Ricerca su tutti i campi

Ricerca avanzata

Tipo pubbl.	Pubblicazione
Conference Abstract	Hillmen P, Robak T, Janssens A, Govindbabu K, Grosicki S, Mayer J, Panagiotidis P, Kimby E, Schuh A, Boyd T, Montillo M, McKeown A, Carey J L, Gupta I V, Chang C -N, Lisby S, Offner F Ofatumumab + chlorambucil versus chlorambucil alone in patients with untreated Chronic Lymphocytic Leukemia (CLL): Results of the phase III study complement 1 (OMB110911) Blood 2013;122(21): - .
Conference Abstract	Hofheinz R, Grothey A, Sobrero A F, Siena S, Falcone A, Ychou M, Humblet Y, Bouche O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz H -J, Goldberg R M, Wagner A, Cihon F, Van Cutsem E Time course of regorafenib-associated adverse events in the phase III CORRECT study Onkologie 2013;36( ):117-118.
Retrospective Studies; Multicenter Study	Iacovelli R, Carteni G, Sternberg C N, Milella M, Santoni M, Di Lorenzo G, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Ruggeri E M, Berruti A Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: Results from a large patient cohort Eur J Cancer 2013;49(9):2134-2142.
Letter; Journal Article	Iacovoni A, De Maria R, Gavazzi A, Grosu A, Fontana A, Guideri S, Gori M, Ferrari P, Filippi A, Rutili M R, Donzelli L, Parolini M, Senni M Natriuretic peptides and the Framingham Risk score for screening of asymptomatic left ventricular systolic dysfunction in high-risk patients in primary care. The DAVID-BERG study Int J Cardiol 2013;168(5):5093-5095.
Journal Article	Iannone F, Gremese E, Gallo G, Sarzi-Puttini P, Botsios C, Trotta F, Gasperini S, Galeazzi M, Adami S, Cantini F, Sebastiani M, Gorla R, Marchesoni A, Giardina A, Foti R, Mele A, Bruschi E, Bagnato G, Erre G L, Lapadula G High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register Clin Rheumatol 2014;33(1):31-37. Pubblicazione Elettronica: 2013
Research Support; Multicenter Study	Imazio M, Belli R, Brucato A, Ferrazzi P, Patrini D, Martinelli L, Polizzi V, Cemin R, Leggieri A, Caforio A L P, Finkelstein Y, Hoit B, Maisch B, Mayosi B M, Oh J K, Ristic A D, Seferovic P, Spodick D H, Adler Y Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): A randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of th Am Heart J 2013; ( ): - .
Letter; Journal Article	Incorvaia C, Vighi G, Ridolo E Systematic reviews and heterogeneity Ann Allergy Asthma Immunol 2013;111(4):306- .
Case Reports	Invernizzi P, Gandola M, Romano D, Zapparoli L, Bottini G, Paulesu E What is mine? Behavioral and anatomical dissociations between somatoparaphrenia and anosognosia for hemiplegia Behav Neurol 2013;26():139-150.
Conference Abstract	Jeffers M, Van Cutsem E, Sobrero A F, Siena S, Falcone A, Ychou M, Humblet Y, Bouche O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz H -J, Goldberg R M, Sargent D J, Cihon F, Wagner A, Laurent D, Grothey A Mutational analysis of biomarker samples from the CORRECT study: Correlating mutation status with clinical response to regorafenib J Clin Oncol 2013;31(4 Suppl 1):- .
Conference Abstract	Kallmes D, Boccardi E, Bonafe A, Cekirge S, Fiorella D, Hanel R, Jabbour P, Levy E, Lopes D, Lylyk P, McDougall C, Siddiqui A, Szikora I, Woo H Safety of flow diversion: Results from a multicentre registry J Neurointervent Surg 2013;5( ):A6- .
Conference Abstract	Karthaus M, Jeffers M, Van Cutsem E, Sobrero A F, Siena S, Falcone A, Ychou M, Humblet Y, Bouche O, Mineur L, Barone C, Adenis A, Tebernero J, Yoshino T, Lenz H -J, Goldberg R M, Wagner A, Grothey A Mutational analysis of biomarker samples from the CORRECT study: Correlating mutation status with clinical response to regorafenib Onkologie 2013;36( ):117- .
Conference Abstract	Karthaus M, Lenz H -J, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouche O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Goldberg R M, Cihon F, Wagner A, Grothey A Analysis of plasma protein biomarkers from the CORRECT phase III study of regorafenib for metastatic colorectal cancer Onkologie 2013;36( ):68-69.
Conference Abstract	Kaveh Moghadam K, Pizza F, Franceschini C, Peltola H, Vandi S, Finotti E, Ingravallo F, Nobili L, Bruni O, Dauvilliers Y, Lin L, Edwards M J, Partinen M, Mignot E, Bhatia K, Plazzi G Evolution of the clinical and polysomnographic picture of childhood narcolepsy with cataplexy following disease onset J Neurol 2013;260( ):S85-S86.
Conference Abstract	Kloppe A, Gasparini M, Proclemer A, Lunati M, Ferrer J B M, Hersi A, Gulaj M, Wijffels M, Santi E, Manotta L, Mangoni L, Arenal A Avoiding inappropriate shocks: Data from the ADVANCEIII trial Heart Rhythm 2013;10(5 Suppl 1):S475.
Journal Article	Kola B, Wittman G, Bodnar I, Amin F, Lim C T, Olah M, Christ-Crain M, Lolli F, Van Thuijl H, Leontiou C A, Fuzesi T, Dalino P, Isidori A M, Harvey-White J, Kunos G, Nagy G M, Grossman A B, Fekete C, Korbonits M The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release FASEB J 2013;27(12):5112-5121.
Case Reports	La Verde N, Piva S, Colombo F, Borgonovo K, Gramegna G, Girelli S, Dimaiuta M, Galfrascoli E, Battaglia E, Farina G Lung infiltrates in cancer patients: Differentiating metastases from bronchiolitis obliterans organizing pneumonia Immunopharmacol Immunotoxicol 2013;35(1):195-197.
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Minola E, Cologni G, Rizzi M, Zaltron S, Vavassori A, Castelli F, Angeli E, Gubertini G A, Magni C, Rizzardini G, Testa A, D'Offizi G, Vinci M, Pinzello G, Fatta E, Fargion S, Colombo S, Fracassetti O, Del Poggio P, 5-year entecavir treatment in NUC-naive, field-practice patients with chronic hepatitis B showed excellent viral suppression and safety profile but no prevention of HCC in cirrhotics J Hepatol 2013;58(Suppl 1):S306-S307.
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Minola E, Cologni G, Rizzi M, Zaltron S, Vavassori A, Castelli F, Angeli E, Gubertini G A, Magni C, Rizzardini G, Testa A, D'Offizi G, Vinci M, Pinzello G, Fatta E, Fargion S, Colombo S, Fracassetti O, Del Poggio P, 5-year entecavir in NUC-naive, field-practice patients with CHB showed excellent viral suppression and safety but no prevention of HCC Dig Liver Dis 2013;45(Suppl 1):S16- .
Conference Abstract	Lampertico P, Soffredini R, Vigano M, Yurdaydin C, Idilman R, Papatheodoridis G V, Margariti E, Buti M, Esteban R, Zaltron S, Vavassori A, Carosi G, Minola E, Vinci M, Pinzello G, Giorgini A M, Zuin M, Salmi A, Colombo S, Fracassetti O, Del Poggio P, Br Tenofovir suppressed viral suppression in most field practice, treatment-naive patients with CHB followed for 3 years in a multicenter European study Dig Liver Dis 2013;45(Suppl 1):S16-S17.
Conference Abstract	Lampertico P, Soffredini R, Yurdaydin C, Idilman R, Papatheodoridis G V, Margariti E, Buti M, Esteban R, Zaltron S, Vavassori A, Castelli F, Vigano M, G Rumi M, Vinci M, Belli L S, Cologni G, Rizzi M, Milanese M, Strazzabosco M, Minola E, Giorgini A M, Zuin M, Salmi A, Colombo S, Fracassetti O, Poggio P D, Bruno S, Fagiuoli S, Andreoletti M, Colli A, Colombo A E, Bellati G A, Magni C F, Angeli E, Gubertini G A, Fasano M, Santantonio T A, Terreni N M, Mangia G, Colombo M Four years of tenofovir monotherapy for NUC naive field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis Hepatology 2013;58(4):653A- .

Risultati da 3441 a 3460 di 6391 totali

Precedente -

- Successiva

AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA | Piazza Ospedale Maggiore 3 | 20162 Milano | t. +39 02 6444.1 - f. +39 02 6420901 | CF e Partita IVA: 11390840152